- Home
- NVS vs PM Comparison
NVS vs PM Comparison
Compare NVS & PM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- PM
- Stock Information
- Founded
- NVS 1895
- PM 1987
- Country
- NVS Switzerland
- PM United States
- Employees
- NVS N/A
- PM N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- PM Medicinal Chemicals and Botanical Products
- Sector
- NVS Health Care
- PM Health Care
- Exchange
- NVS Nasdaq
- PM Nasdaq
- Market Cap
- NVS 230.5B
- PM 277.4B
- IPO Year
- NVS 1991
- PM N/A
- Fundamental
- Price
- NVS $115.75
- PM $180.52
- Analyst Decision
- NVS Hold
- PM Strong Buy
- Analyst Count
- NVS 6
- PM 12
- Target Price
- NVS $123.67
- PM $159.58
- AVG Volume (30 Days)
- NVS 1.7M
- PM 5.4M
- Earning Date
- NVS 07-17-2025
- PM 07-22-2025
- Dividend Yield
- NVS 3.45%
- PM 2.99%
- EPS Growth
- NVS N/A
- PM N/A
- EPS
- NVS 6.38
- PM 4.86
- Revenue
- NVS $53,222,000,000.00
- PM $38,386,000,000.00
- Revenue This Year
- NVS $7.22
- PM $11.90
- Revenue Next Year
- NVS $1.94
- PM $8.31
- P/E Ratio
- NVS $17.41
- PM $37.16
- Revenue Growth
- NVS 11.50
- PM 6.78
- 52 Week Low
- NVS $96.06
- PM $98.93
- 52 Week High
- NVS $120.92
- PM $181.36
- Technical
- Relative Strength Index (RSI)
- NVS 62.89
- PM 69.99
- Support Level
- NVS $111.06
- PM $174.93
- Resistance Level
- NVS $113.91
- PM $179.83
- Average True Range (ATR)
- NVS 1.57
- PM 2.78
- MACD
- NVS 0.45
- PM 0.45
- Stochastic Oscillator
- NVS 98.99
- PM 95.58
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
About PM Philip Morris International Inc
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.